Gutierrez-Ramos Jose-Carlos has filed 35 insider transactions across 2 companies since April 2022.
Most recent transaction: a grant/award of 17964 shares of DANAHER CORP /DE/ ($DHR) on March 01, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Employee stock option (right to buy) | 17964 | $0.00 | 17,964.0000 | 717,900,000 | 9999.99% | 0.00% |
| March 1, 2026 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | F | Common Stock | 284 | $210.64 | 19,018.0000 | 717,900,000 | 1.47% | 0.00% |
| March 1, 2026 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Common Stock | 6647 | $0.00 | 19,302.0000 | 717,900,000 | 52.52% | 0.00% |
| Feb. 24, 2026 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | F | Common Stock | 344 | $209.19 | 12,655.0000 | 717,900,000 | 2.65% | 0.00% |
| Feb. 4, 2026 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Common Stock | 1695 | $0.00 | 12,999.0000 | 717,900,000 | 14.99% | 0.00% |
| Feb. 2, 2026 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | F | Common Stock | 852 | $223.42 | 11,304.0000 | 717,900,000 | 7.01% | 0.00% |
| Feb. 2, 2026 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Danaher Deferred Compensation Programs - Danaher Stock Fund | 275 | $218.89 | 1,447.2960 | 717,900,000 | 23.46% | 0.00% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Gutierrez-Ramos Jose-Carlos | Not found | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 69,303,746 | 9999.99% | 0.03% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Gutierrez-Ramos Jose-Carlos | Not found | A | Ordinary Shares | 9500 | $0.00 | 32,500.0000 | 69,303,746 | 41.30% | 0.01% |
| March 1, 2025 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | F | Common Stock | 216 | $207.76 | 12,156.0000 | 737,200,000 | 1.75% | 0.00% |
| March 1, 2025 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Employee stock option (right to buy) | 24067 | $0.00 | 24,067.0000 | 737,200,000 | 9999.99% | 0.00% |
| Feb. 24, 2025 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | F | Common Stock | 586 | $211.14 | 12,372.0000 | 737,200,000 | 4.52% | 0.00% |
| Feb. 1, 2025 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Danaher Deferred Compensation Programs - Danaher Stock Fund | 241 | $222.74 | 1,172.2960 | 737,200,000 | 25.88% | 0.00% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Gutierrez-Ramos Jose-Carlos | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 58,207,593 | 9999.99% | 0.02% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Gutierrez-Ramos Jose-Carlos | Not found | A | Ordinary Shares | 6250 | $0.00 | 23,000.0000 | 58,207,593 | 37.31% | 0.01% |
| March 1, 2024 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Employee stock option (right to buy) | 6979 | $0.00 | 6,979.0000 | 743,100,000 | 9999.99% | 0.00% |
| March 1, 2024 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Common Stock | 2932 | $0.00 | 12,958.0000 | 743,100,000 | 29.24% | 0.00% |
| March 1, 2024 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Employee stock option (right to buy) | 16285 | $0.00 | 16,285.0000 | 743,100,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | F | Common Stock | 866 | $253.84 | 10,026.0000 | 743,100,000 | 7.95% | 0.00% |
| Feb. 21, 2024 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Common Stock | 3155 | $0.00 | 10,892.0000 | 743,100,000 | 40.78% | 0.00% |
| Feb. 1, 2024 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Danaher Deferred Compensation Programs - Danaher Stock Fund | 216 | $0.00 | 931.2960 | 743,100,000 | 30.20% | 0.00% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Gutierrez-Ramos Jose-Carlos | Director | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 35,592,362 | 9999.99% | 0.03% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Gutierrez-Ramos Jose-Carlos | Director | A | Ordinary Shares | 6000 | $0.00 | 16,750.0000 | 35,592,362 | 55.81% | 0.02% |
| Aug. 21, 2023 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | S | Common Stock | 590 | $250.54 | 6,939.0000 | 737,100,000 | 7.84% | 0.00% |
| May 1, 2023 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | S | Common Stock | 500 | $242.19 | 7,529.0000 | 737,100,000 | 6.23% | 0.00% |
| April 28, 2023 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Danaher Deferred Compensation Programs - Danaher Stock Fund | 1 | $236.91 | 635.3780 | 737,100,000 | 0.11% | 0.00% |
| Feb. 24, 2023 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Employee stock option (right to buy) | 10849 | $0.00 | 10,849.0000 | 737,100,000 | 9999.99% | 0.00% |
| Feb. 24, 2023 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Employee stock options (right to buy) | 16274 | $0.00 | 16,274.0000 | 737,100,000 | 9999.99% | 0.00% |
| Feb. 24, 2023 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Common Stock | 4015 | $0.00 | 8,029.0000 | 737,100,000 | 100.02% | 0.00% |
| Feb. 24, 2023 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | F | Common Stock | 481 | $249.12 | 4,014.0000 | 737,100,000 | 10.70% | 0.00% |
| Feb. 1, 2023 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Danaher Deferred Compensation Programs - Danaher Stock Fund | 461 | $267.50 | 634.6550 | 737,100,000 | 265.47% | 0.00% |
| April 29, 2022 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Danaher Deferred Compensation Programs - Danaher Stock Fund | 0 | $251.13 | 173.4920 | 0 | 0.10% | 0.00% |
| Jan. 27, 2023 | DANAHER CORP /DE/ | $DHR | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | A | Danaher Deferred Compensation Programs - Danaher Stock Fund | 0 | $265.98 | 173.6550 | 737,100,000 | 0.09% | 0.00% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Gutierrez-Ramos Jose-Carlos | Director | A | Stock Option (right to buy) | 11500 | $0.00 | 11,500.0000 | 29,660,659 | 9999.99% | 0.04% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Gutierrez-Ramos Jose-Carlos | Director | A | Ordinary Shares | 5750 | $0.00 | 10,750.0000 | 29,660,659 | 115.00% | 0.02% |